The carbohydrate-protein linkage region of a chondroitin 4-sulfate chain attached to urinary trypsin inhibitor (UTI) was isolated from human urine and characterized structurally. The chondroitin 4-sulfate chain was released from UTI by p-elimination using alkaline NaBH, then digested with chondroitinase ABC. These treatments resulted in only a single hexasaccharide alditol derived from the carbohydrateprotein linkage region. Chemical and enzymic analyses and 600-MHz 'H-NMR spectroscopy revealed that the hexasaccharide alditol had the following structure: AHexAal-3GalNAc(4-sulfate)~1-4GlcA~l-3Gal(4-sulfate)~1-3Gal~l-4Xyl-o1, where AHexA, GlcA and Xyl-ol represent 4-deoxy-a-~-threo-hex-4-enepyranosyluronic acid, D-ghCUroniC acid and D-xylitol, respectively. This structure contained the novel 4-sulfated Gal residue, which was first demonstrated in one of the three linkage hexasaccharide-serines isolated from chondroitin 4-sulfate of rat chondrosarcoma [Sugahara, K., Yamashina, I., de Waard, P., Van Halbeek, H. & Vliegenthart, J. F. G. (1988) J. Bid. Chem. 263, 10168-101741. This disulfated structure was recently identified as the sole structural component in the linkage hexasaccharide alditol fraction isolated from inter-rx-trypsin inhibitor (ITI) in human plasma [ Yamada, S., Oyama, M., Kinugasa, H., Nakagawa, T., Kawasaki, T., Nagasawa, S., Khoo, K.-H., Morris, H. R., Dell, A. & Sugahara, K. (1995) Glycobiology 5, 335 -3411. The structural uniformity in the linkage hexasaccharide structure of IT1 and UTI is in marked contrast to the heterogeneity demonstrated in the linkage hexasaccharides isolated from cartilaginous chondroitin sulfate whose linkage regions are sometimes but not always phosphorylated on the Xyl residue or sulfated on the Gal residue(s). The uniform structure containing the novel 4-sulfated Gal residue in the linkage region of UTI and IT1 may imply its significance in the biosynthetic mechanism of chondroitin sulfate.Keywords: chondroitin sulfate; 'H-NMR; inter-a-trypsin inhibitor; sulfated oligosaccharides; urinary trypsin inhibitor.Urinary trypsin inhibitor (UTI) is a serine-protease inhibitor present in human urine and is a proteoglycan bearing an undersulfated chondroitin 4-sulfate chain (Balduyck et al., 1986: Toyoda et al., 1993. The purified UTI has been used therapeutically in patients with rheumatoid arthritis. Intraarticular injection of UTI improves the symptoms and clinical signs of rheumatoid arthritis markedly, which is ascribed to the inhibition of a plasminogen activator of the urokinase type (Kikuchi et al., 1987). The inhibitory activity of UTI i s attributable to the protein moiety (Gebhard et al., 1989), which consists of 143 amino acids (Wachter and Hochstrasser, 1981) identical in amino acid sequence to that of the L chain, bikunin, of inter-a-trypsin inhibitor (ITI) (Morii and Travis, 1985: Reisinger et al., 1985). IT1 is considered to be a metabolic precursor of UTI (Hochstrasser Corre.~pondeizce fo K. Sugahara, Department of Biochemistry, Kobe Pharmaceutical University, H...